From: Cell cycle correlated genes dictate the prognostic power of breast cancer gene lists
 |  | Intercept adjusted | PC1 adjusted | PC2 adjusted | |||
---|---|---|---|---|---|---|---|
Data set | Gene list | Good/Poor2 | HR (p-value) | Good/Poor2 | HR (p-value) | Good/Poor2 | HR (p-value) |
NKI2 | Â | Â | Â | Â | Â | Â | Â |
 | 70 Gene | 91/174 | 5.8 (< 0.0001) | 30/235 | 1.2 (0.67) | 90/175 | 5.7 (< 0.0001) |
 | Wang 76-gene (ER+) | 85/60 | 4.5 (< 0.0001) | 44/101 | 0.9 (0.84) | 89/56 | 2.7 (0.005) |
 | Wang 76-gene (ER-) | 6/29 | 0.9 (0.88) | 5/30 | 1.2 (0.78) | 8/27 | 0.5 (0.25) |
 | Wound Signature | 74/221 | 4.1 (0.0002) | 27/268 | 1 (0.93) | 73/22 | 3.9 (0.0002) |
 | Sotiriou Grade | 92/203 | 4.7 (< 0.0001) | 25/270 | 0.8 (0.8) | 91/204 | 4.7 (< 0.0001) |
 | Naderi | 131/104 | 2.5 (0.0006) | 123/112 | 0.4 (0.003)2 | 128/107 | 2.4 (0.0014) |
KJX64/KJ125 | Â | Â | Â | Â | Â | Â | Â |
 | 70 Gene | 38/111 | 2.8 (0.03) | 15/134 | 0.7 (0.4) | 39/110 | 2.9 (0.03) |
 | Wang 76-gene (ER+) | 53/36 | 1.6 (0.32) | 35/54 | 1.2 (0.7) | 61/28 | 1.8 (0.24) |
 | Wang 76-gene (ER-)4 | 14/5 | n/a | 16/3 | n/a | 12/7 | n/a |
 | Sotiriou Grade | 46/143 | 2.9 (0.03) | 35/154 | 1.7 (0.24) | 46/143 | 2.7 (0.03) |
 | Naderi | 71/56 | 3.9 (0.004) | 69/58 | 1.6 (0.24) | 72/55 | 3.9 (0.004) |
Wang | Â | Â | Â | Â | Â | Â | Â |
 | 70 Gene | 49/197 | 2.6 (0.005) | 22/224 | 0.9 (0.41) | 44/202 | 2.3 (0.015) |
 | Wang 76-gene (ER+) | 45/84 | 6.3 (0.0005) | 30/99 | 2 (0.11) | 49/80 | 5.6 (0.0003) |
 | Wang 76-gene (ER-) | 26/16 | 11.7 (0.0001) | 29/13 | 8.2 (0.0001) | 15/27 | 4.9 (0.03) |
 | Sotiriou Grade | 57/229 | 2.5 (0.007) | 21/265 | 0.7 (0.25) | 49/237 | 2 (< 0.0001) |
 | Naderi | 106/110 | 2.4 (0.0008) | 105/111 | 0.9 (0.66) | 105/111 | 3.1 (< 0.0001) |